| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Patrick J. Beyer
Also a director
President and Chief Executive Officer
|
60 |
Since 2025
1 year
|
$7,634,873 | |
|
John E. Gallagher
Executive Vice President, Chief Financial Officer
Title from the Form 8-K dated Jul 15, 2026
|
Not stated | Not stated | Not reported | |
|
Hollie Foust
General Counsel & Corp Sec
Title from the Form 4 dated Nov 4, 2026
|
51 | Not stated | $1,842,776 | |
|
Richard Glaze
Chief Information Officer
|
60 |
Since 2023
3 years
|
Not reported | |
|
John David Ferrell
EVP, Human Resources
|
58 |
Since 2022
4 years
|
Not reported | |
|
Brent Lalomia
EVP, Regulatory Affairs, Quality Assurance, Clinical Affairs, Commercial Operations, and IT
|
51 |
Since 2025
1 year
|
$1,662,776 | |
|
Peter K. Shagory
EVP, Strategy and Corporate Development
|
57 |
Since 2015
11 years
|
$1,563,789 | |
|
Andrew Moller
VP Corporate Controller
Title from the Form 4 dated Mar 2, 2026
|
51 | Not stated | Not reported | |
|
Johonna Pelletier
Treasurer and VP, Tax
|
53 |
Since 2015
11 years
|
Not reported | |
|
Matthew Schabacker
VP and General Manager, U.S. Advanced Surgical
|
45 |
Since 2025
1 year
|
Not reported | |
|
Kimberly Lockwood
Interim Corporate Controller and Senior Director, Financial Reporting and Controls
Title from the Form 8-K dated Jun 17, 2026
|
Not stated | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 7, 2026 · updated by the 8-K of May 20, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
LaVerne H. Council
Board chair
|
64 |
2019
7 years
|
Not stated |
Compensation
Corporate Governance and Nominating · Chair
|
Thomson Reuters Corporation | $308,004 | |
|
Patrick J. Beyer
CEO
|
60 |
2025
1 year
|
Not stated | None stated | Bioventus Inc. | Paid as CEO | |
|
David Bronson
|
72 |
2015
11 years
|
Not stated | None stated | None stated | $282,134 | |
|
Charles M. Farkas
|
74 |
2014
12 years
|
Not stated |
Corporate Governance and Nominating
Strategy · Chair
|
None stated | $278,746 | |
|
Mark Kaye
|
46 |
2025
1 year
|
Not stated |
Audit
Strategy
|
None stated | $310,733 | |
|
Kim Kelderman
|
58 |
2025
1 year
|
Not stated |
Corporate Governance and Nominating
Strategy
|
None stated | $161,721 | |
|
Barbara J. Schwarzentraub
|
60 |
2019
7 years
|
Not stated |
Audit · Chair
Compensation
|
None stated | $290,356 | |
|
Brian Concannon
|
Not stated | Not stated | Independent | None stated | None stated | $279,994 | |
|
Celine Martin
Joined Jul 1, 2026
|
- | - | Independent |
Audit Committee
Strategy Committee
|
- | - | |
|
Jeff Mirviss
Joined Jul 1, 2026
|
- | - | Independent |
Compensation Committee
Corporate Governance and Nominating Committee
|
- | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Apr 7, 2026 states there were none.
Read it in the proxyLoading...